Skip to main content

Advertisement

SpringerLink
Log in

Rituximab and leflunomide for Wegener’s granulomatosis: a long-term follow-up

  • Letter to the Editor
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Henes JC, Fritz J, Koch S, Klein R, Horger M, Risler T et al (2007) Rituximab for treatment-resistant extensive Wegener’s granulomatosis—additive effects of a maintenance treatment with leflunomide. Clin Rheumatol 26(10):1711–1715

    Article  CAS  PubMed  Google Scholar 

  2. Smith KG, Jones RB, Burns SM, Jayne DR (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 54(9):2970–2982

    Article  CAS  PubMed  Google Scholar 

  3. Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D (2006) Long term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 45(11):1432–1436

    Article  CAS  Google Scholar 

  4. Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44

    Article  CAS  PubMed  Google Scholar 

  5. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG (1996) The Dutch co-trimoxazole Wegener study group. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. N Engl J Med 335:16–20

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II (Oncology, Hematology, Immunology, Rheumatology, Pulmonology), University Hospital Tuebingen, Otfried-Mueller-Str. 10, 72076, Tuebingen, Germany

    J. C. Henes, L. Kanz & I. Koetter

Authors
  1. J. C. Henes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Kanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Koetter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. C. Henes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henes, J.C., Kanz, L. & Koetter, I. Rituximab and leflunomide for Wegener’s granulomatosis: a long-term follow-up. Rheumatol Int 31, 425–426 (2011). https://doi.org/10.1007/s00296-010-1462-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1462-x

Keywords

Search

Navigation